Embryo Morphokinetics, Embryo Morphometry, Embryonic Development
Conditions
Keywords
Embryo culture, reduced oxygen, time-lapse, blastocyst
Brief summary
The purpose of this study is to investigate the development of human embryos in vitro under two different oxygen concentrations; a static 5% during all five days of culture or under an oxygen gradient, starting with 8% from day-0 to day-3, continuing with 5% on day-3 and following with 2% of oxygen from the end of day-3 to day-5.
Detailed description
Several studies have shown that embryonic morphological parameters improved when the oxygen concentration in embryo culture was reduced from 20% to 5%. Early mammalian embryos developed faster, had shorter cell cycles, a higher blastocyst formation rate and a better integrity of the inner cell mass (ICM) compared to embryos cultured at 20% oxygen concentration. Recent studies have shown that the oxygen concentration in the female reproductive tract is not static. In the fallopian tubes of higher mammals it is at around 8%, while in the uterus, at the time of embryo implantation, the oxygen concentration is almost anoxic (2%). Mimicking such physiological conditions that better reflect the in vivo environment in the human reproductive tract is the goal of assisted reproductive technology (ART). The aim of this study is to assess whether changing the static 5% oxygen during five days of in vitro embryo culture to the gradient of oxygen, starting with 8% from day-0 to day-3, continuing with 5% on day-3 and following with 2% of oxygen from the end of day-3 to day-5, better reflects conditions found within the human reproductive tract and improves embryo developmental characteristics.
Interventions
After oocyte retrieval and insemination, half of a given patient's embryos will be randomly allocated in an incubator set at a gradient of oxygen tension (8-5-2%). The embryos will remain in the incubator until their developmental assessments on day 5.
Sponsors
Study design
Masking description
The cohort of oocyte-cumulus complexes will be divided into either the study or control group by simple randomization. All embryologists involved in the study will be blinded during embryo assessment, measurement, and selection for embryo transfer or vitrification. A code system will be used on the Petri dishes to ensure the embryologists are blinded.
Intervention model description
496 sibling oocytes will be randomly allocated for culture either at low oxygen tension (5% O2) (n = 248 oocytes) or a more physiological oxygen gradient (8-5-2% O2) (n = 248 oocytes) for the next 5 days. Immediately after allocation, the oocytes will be inseminated through Intracytoplasmic Sperm Injection (ICSI). The sibling oocytes will always be injected by the same embryologist. Under standard (5%) oxygen concentration, which is currently being used in the cultivating incubators, approximately 15% of all embryos manage to reach a morphological optimal blastocyst, in a patient group younger than 35 years (see Inclusion Criteria). According to the hypothesis that cultivating embryos under a more physiological atmosphere (gradient from 8% to 2%) improves the blastulation rate of embryos to 25%, a sample size of 496 Injected oocytes (248 in each arm), will be needed. Whereby a statistical strength of 80% and α = 0.05 is considered (calculated using power analysis).
Eligibility
Inclusion criteria
* Age of women between 18 and 35 years. * Body mass index (BMI) between 18 and 30 kg/m². * Only patients with ICSI procedure (male factor of infertility, excluding azoospermia) and blastocyst culture. * Patients from first and second ICSI cycle attempt. * Gonadotropin hormone-releasing hormone (GnRH) antagonist cycles.
Exclusion criteria
* Presence of endometriosis. * Previous clinical intervention on ovaries. * Connected endocrine or metabolic diseases. * Presence of polycystic ovary syndrome.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5 | Embryos will be annotated on day 5 post insemination (at 8:00 am). | The primary outcome measure will be the proportion of oocytes that will develop to the morphologically optimal day-5 blastocysts, scored 4-5AA according to Gardner criteria. According to the scoring system of Gardner, blastocyst morphology parameters such as the degree of blastocoel expansion (1-5), the morphological appearance of the inner cell mass (ICM) (A, B, C) and the cohesiveness of trophectoderm (TE) (A, B, C) will be measured. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measured Times From Insemination to Different Embryonic Stages Reached | Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination. | Using time-lapse software, embryo development videos were reviewed by manually advancing the images frame by frame. Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination. The following developmental milestones were recorded for each clinically used embryo that reached the blastocyst stage (cryopreserved or transferred): tPNa - Appearance of individual pronuclei t2 - Time to 2-cell stage t3 - Time to 3-cell stage t4 - Time to 4-cell stage t5 - Time to 5-cell stage t6 - Time to 6-cell stage t7 - Time to 7-cell stage t8 - Time to 8-cell stage tSC - First evidence of compaction tM - Completion of the compaction process (morula stage) tSB - Initiation of blastulation tB - Full blastocyst (last frame before zona pellucida starts to thin) tEB - Initiation of blastocyst expansion (first frame showing zona thinning) |
| Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5 | Fix time (116 hours) post insemination | Surface measurements of blastocysts and inner cell mass (ICM) will be recorded on time-lapse photos at 116 hours after insemination. The surfaces will be measured in square micrometres using the Primo vision software's measuring tool. An ellipse will be generated around the trophectoderm's outer edge or the inner cell mass. These measurements will exclude the zona pellucida. The measurements will be taken at the focus plane with the largest surface area. |
| Number of Trophectoderm Cells on Day 5 | Fix time (116 hours) post insemination. | At 116 hours following insemination, the number of trophectoderm cells will be counted using time-lapse photos. Images will be focused on the trophectoderm's outermost edge to better determine the boundaries of each individual cell. |
| Incidence of Atypical Embryo Cleavages | Continuously (a picture will be taken every 5 minutes) during 5 days of embryo culture. | Time-lapse videos for each embryo will be reviewed for atypical cleavage features, such as; pseudofurrows, direct cleavage, reverse cleavage, multinucleation, irregular chaotic division, cell exclusion and blastocyst collapse, using Primo vision software by manually forwarding the images frame by frame. The frequency of abnormal cleavage patterns will be recorded. |
Countries
Slovenia
Participant flow
Recruitment details
Participants were recruited between January 2022 and January 2023 at the University Medical Centre Maribor. Women under 35 undergoing ICSI for male infertility were included. All patients provided informed consent. A total of 44 participants were enrolled, with a total of 658 cumulus-oocyte complexes (COCs) collected.
Pre-assignment details
Following oocyte pickup, 625 cumulus-oocyte complexes from 44 ICSI cycles were allocated to two groups by quasi randomisation. After excluding immature (GV/MI) or degenerated oocytes, 521 metaphase II (MII) oocytes remained, with 258 assigned to the control group (5% O₂) and 263 to the intervention group (8-5-2% O₂).
Participants by arm
| Arm | Count |
|---|---|
| All Study Participants As a sibling oocyte study, individual patients were not assigned to groups; instead, all 44 enrolled female patients had their sibling oocytes allocated between the intervention and control conditions. Thus, a single cohort of patients served as the baseline population. | 44 |
| Total | 44 |
Baseline characteristics
| Characteristic | All Study Participants | — |
|---|---|---|
| Age, Continuous | 31.4 Years STANDARD_DEVIATION 2.36 | — |
| Race and Ethnicity Not Collected | — | — Participants |
| Sex: Female, Male Female | 44 Participants | — |
| Sex: Female, Male Male | 0 Participants | — |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5
The primary outcome measure will be the proportion of oocytes that will develop to the morphologically optimal day-5 blastocysts, scored 4-5AA according to Gardner criteria. According to the scoring system of Gardner, blastocyst morphology parameters such as the degree of blastocoel expansion (1-5), the morphological appearance of the inner cell mass (ICM) (A, B, C) and the cohesiveness of trophectoderm (TE) (A, B, C) will be measured.
Time frame: Embryos will be annotated on day 5 post insemination (at 8:00 am).
Population: The primary outcome measure is the proportion of inseminated MII oocytes that develop into morphologically optimal day-5 blastocysts, defined as grade 4-5AA according to the Gardner criteria and not the enrolled patient coupled (n=44)
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5 | 27 Oocytes |
| Control (no Intervention) | Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5 | 38 Oocytes |
Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5
Surface measurements of blastocysts and inner cell mass (ICM) will be recorded on time-lapse photos at 116 hours after insemination. The surfaces will be measured in square micrometres using the Primo vision software's measuring tool. An ellipse will be generated around the trophectoderm's outer edge or the inner cell mass. These measurements will exclude the zona pellucida. The measurements will be taken at the focus plane with the largest surface area.
Time frame: Fix time (116 hours) post insemination
Population: Blastocysts graded Gardner ≥3 were included, as they exhibited sufficient morphological development for accurate measurement of blastocyst and inner cell mass (ICM) surface areas.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5 | Blastocyst surface area (P, µm²) | 25994 µm² | Standard Deviation 4657 |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5 | Inner cell mass surface area (ICM, µm²) | 3695 µm² | Standard Deviation 732.5 |
| Control (no Intervention) | Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5 | Blastocyst surface area (P, µm²) | 28198 µm² | Standard Deviation 4139 |
| Control (no Intervention) | Blastocyst and Inner Cell Mass (ICM) Surface Area Measurement on Day 5 | Inner cell mass surface area (ICM, µm²) | 3628 µm² | Standard Deviation 831.9 |
Incidence of Atypical Embryo Cleavages
Time-lapse videos for each embryo will be reviewed for atypical cleavage features, such as; pseudofurrows, direct cleavage, reverse cleavage, multinucleation, irregular chaotic division, cell exclusion and blastocyst collapse, using Primo vision software by manually forwarding the images frame by frame. The frequency of abnormal cleavage patterns will be recorded.
Time frame: Continuously (a picture will be taken every 5 minutes) during 5 days of embryo culture.
Population: The analysis included all embryos that progressed to the blastocyst stage.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Incidence of Atypical Embryo Cleavages | Pseudofurrows | 36 Number of events |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Incidence of Atypical Embryo Cleavages | Direct cleavage | 25 Number of events |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Incidence of Atypical Embryo Cleavages | Reverse cleavage | 14 Number of events |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Incidence of Atypical Embryo Cleavages | Irregular chaotic division | 21 Number of events |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Incidence of Atypical Embryo Cleavages | Blastomere exclusion | 45 Number of events |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Incidence of Atypical Embryo Cleavages | Blastocyst collapse | 55 Number of events |
| Control (no Intervention) | Incidence of Atypical Embryo Cleavages | Blastomere exclusion | 34 Number of events |
| Control (no Intervention) | Incidence of Atypical Embryo Cleavages | Pseudofurrows | 49 Number of events |
| Control (no Intervention) | Incidence of Atypical Embryo Cleavages | Irregular chaotic division | 15 Number of events |
| Control (no Intervention) | Incidence of Atypical Embryo Cleavages | Direct cleavage | 30 Number of events |
| Control (no Intervention) | Incidence of Atypical Embryo Cleavages | Blastocyst collapse | 67 Number of events |
| Control (no Intervention) | Incidence of Atypical Embryo Cleavages | Reverse cleavage | 9 Number of events |
Measured Times From Insemination to Different Embryonic Stages Reached
Using time-lapse software, embryo development videos were reviewed by manually advancing the images frame by frame. Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination. The following developmental milestones were recorded for each clinically used embryo that reached the blastocyst stage (cryopreserved or transferred): tPNa - Appearance of individual pronuclei t2 - Time to 2-cell stage t3 - Time to 3-cell stage t4 - Time to 4-cell stage t5 - Time to 5-cell stage t6 - Time to 6-cell stage t7 - Time to 7-cell stage t8 - Time to 8-cell stage tSC - First evidence of compaction tM - Completion of the compaction process (morula stage) tSB - Initiation of blastulation tB - Full blastocyst (last frame before zona pellucida starts to thin) tEB - Initiation of blastocyst expansion (first frame showing zona thinning)
Time frame: Morphokinetic timings were recorded continuously (every 5 minutes) throughout embryo culture, up to 124 hours (Day 5) post-insemination.
Population: Embryos included in the analysis were those that progressed to the blastocyst stage and were deemed suitable for clinical use, either through transfer or cryopreservation.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t3 | 36.6 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t8 | 69.5 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t5 | 49.5 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | tSC | 86.0 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t2 | 25.7 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | tM | 91.2 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t6 | 53.2 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | tSB | 106.1 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t4 | 38.8 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | tB | 112.4 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | t7 | 61.5 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | tEB | 117.0 Hours post-insemination (HPI) |
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Measured Times From Insemination to Different Embryonic Stages Reached | tPNa | 11.4 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | tEB | 111.4 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | tPNa | 11.7 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t2 | 25.7 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t3 | 35.1 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t4 | 37.6 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t5 | 48.1 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t6 | 53.1 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t7 | 63.4 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | t8 | 71.9 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | tSC | 83.8 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | tM | 88.3 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | tSB | 100.8 Hours post-insemination (HPI) |
| Control (no Intervention) | Measured Times From Insemination to Different Embryonic Stages Reached | tB | 106.9 Hours post-insemination (HPI) |
Number of Trophectoderm Cells on Day 5
At 116 hours following insemination, the number of trophectoderm cells will be counted using time-lapse photos. Images will be focused on the trophectoderm's outermost edge to better determine the boundaries of each individual cell.
Time frame: Fix time (116 hours) post insemination.
Population: Blastocysts graded Gardner ≥3 were included, as these embryos exhibited sufficient morphological development to enable accurate count of trophectoderm (TE) cell number.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| 8-5-2% Oxygen Gradient Concentration in the Incubator | Number of Trophectoderm Cells on Day 5 | 14.4 Number of cells | Standard Deviation 2.3 |
| Control (no Intervention) | Number of Trophectoderm Cells on Day 5 | 15.3 Number of cells | Standard Deviation 2.8 |